Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00597129 · ClinicalTrials.gov registry record · Phase 1
Safety and Efficacy Study of 90Y-hPAM4 at Different Doses
A Phase 1 study, sponsored by Gilead Sciences.
- Completed
- Registry status
- Phase 1
- Development phase
- 21
- Enrollment target
NCT00597129 is a Phase 1 study that has completed, run by Gilead Sciences. The registered enrollment target is 21 participants.
The verdict
NCT00597129, a Phase 1 study, has completed, sponsored by Gilead Sciences.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 21 participants
- Enrollment target
Study Summary
Safety study to determine highest dose of 90Y-hPAM4 can be safety administered
Interventions
- BIOLOGICAL 90Y-hPAM4
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 21 participants |
| Start Date | 2004-08 |
| Est. Completion | 2007-10 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00597129
The ClinicalTrials.gov registry entry for NCT00597129 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 21 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Gilead Sciences, which has 504 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which 90Y-hPAM4 is the first listed.
NCT00597129 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00597129 about?
NCT00597129 is a clinical study titled "Safety and Efficacy Study of 90Y-hPAM4 at Different Doses". Safety study to determine highest dose of 90Y-hPAM4 can be safety administered
What is the current status of trial NCT00597129?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 21 participants. The study started on 2004-08. Estimated completion is 2007-10.
What interventions are being tested in trial NCT00597129?
The interventions under investigation include: 90Y-hPAM4 (BIOLOGICAL).
Who is sponsoring clinical trial NCT00597129?
This trial is sponsored by Gilead Sciences, which has 504 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.